Citations 1
First-line nivolumab (NIVO) plus ipilimumab (IPI) versus chemotherapy (chemo) for the treatment of unresectable malignant pleural mesothelioma (MPM): Patient-reported outcomes (PROs) from CheckMate 743
Scherpereel, Arnaud , Antonia, Scott , Bautista, Y., Zalcman, Gérard , Sun, Xuezheng , Padilla, Brad , Aanur, Praveen , Daumont, M. , Bennett, Bryan , McKenna, M., Baas, P, Zalcman, Gérard , Bischoff, Hervé , Grossi, Francesco , Kowalski, Dariusz M. , Nowak, Anna K. , Fujimoto, Nobukazu , Peters, Solange , Tsao, Anne S. , Mansfield, Aaron S. , Popat, Sanjay , Bennett, B, Baas, P
Pneumologie | October 26, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available
